XML 40 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727
Significant Accounting Policies (Policy)
6 Months Ended
Jul. 04, 2015
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation:  The financial statements and accompanying notes have been prepared on a consolidated basis and reflect the consolidated financial position of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated from these financial statements. The Company’s fiscal year ends on the Saturday closest to December 31.    Every fifth or sixth fiscal year, the inclusion of an extra week occurs due to the Company’s floating year-end date. The fiscal year 2014 ended on January 3, 2015 consisted of 53 weeks. The fiscal year 2015 ending on January 2, 2016 will include the normal 52 weeks.

Changes in accounting principle

Changes in accounting principle: In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.  The amendments in this ASU require that debt issuance costs related to a debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.  The recognition and measurement guidance for debt issuance costs have not changed.

 

The Company early adopted the amendments in this ASU effective as of April 4, 2015.  As of July 4, 2015 and January 3, 2015, the Company had unamortized debt issuance costs of $85,161 and $91,361, respectively.  The Company had previously presented the debt issuance costs as other noncurrent assets in its consolidated balance sheet as of January 3, 2015 in the Company’s Annual Report on Form 10-K filed with the Commission on March 19, 2015.  The early adoption has resulted in adjustments to the Company’s consolidated balance sheet as of January 3, 2015, by reclassifying the debt issuance costs as a direct deduction from the carrying amount of the debt liability.  Below are the effects of the change on the consolidated balance sheet as of January 3, 2015.

 

ChromaDex Corporation and Subsidiaries  
   
Condensed Consolidated Balance Sheet  
January 3, 2015  
                   
   

Previously

Reported

    Adjustments     As Adjusted  
Assets                  
                   
Current Assets   $ 9,898,691     $ -     $ 9,898,691  
                         
Leasehold Improvements and Equipment, net     1,264,660       -       1,264,660  
                         
Other Noncurrent Assets     444,857       (91,361 )     353,496  
                         
Total assets   $ 11,608,208     $ (91,361 )   $ 11,516,847  
                         
Liabilities and Stockholders' Equity                        
                         
Current Liabilities   $ 4,980,820     $ -     $ 4,980,820  
                         
Loan payable, less current maturities, net     2,068,474       (91,361 )     1,977,113  
                         
Capital lease obligations, less current maturities     423,015       -       423,015  
                         
Deferred rent, less current     137,508       -       137,508  
                         
Total liabilities     7,609,817       (91,361 )     7,518,456  
                         
Total stockholders' equity     3,998,391       -       3,998,391  
                         
Total liabilities and stockholders' equity   $ 11,608,208     $ (91,361 )   $ 11,516,847  
Inventories

Inventories:  Inventories are comprised of raw materials, work-in-process and finished goods.  They are stated at the lower of cost, determined by the first-in, first-out method (FIFO) method, or market.  Labor and overhead has been added to inventory that was manufactured or characterized by the Company.  The amounts of major classes of inventory as of July 4, 2015 and January 3, 2015 are as follows:

 

    July 4, 2015     January 3, 2015  
Natural product fine chemicals   $ 1,695,315     $ 1,760,305  
Bulk ingredients     1,957,718       2,298,036  
      3,653,033       4,058,341  
Less valuation allowance     564,000       324,000  
    $ 3,089,033     $ 3,734,341